Updated Jul 16, 2026
Sukhtian Faisal Ghiath has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $50K.
Sukhtian Faisal Ghiath is a corporate executive currently serving as a Director at Outlook Therapeutics, Inc. His professional background includes experience in the biotechnology and pharmaceutical sectors, although specific details about his career history are not widely documented.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | OTLK | Outlook Therapeutics, Inc. | P — Open-market purchase | 122.2K | $0.41 | $50K |
Sukhtian Faisal Ghiath is a corporate executive currently serving as a Director at Outlook Therapeutics, Inc. His professional background includes experience in the biotechnology and pharmaceutical sectors, although specific details about his career history are not widely documented.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($50K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sukhtian Faisal Ghiath profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.